# Oral Contraceptive Interaction Study for GW273225

> **NCT00483535** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** GW273225
- **DRUG:** COC

## Key facts

- **NCT ID:** NCT00483535
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03-07
- **Primary completion:** 2007-11-16
- **Final completion:** 2007-11-16
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483535, "Oral Contraceptive Interaction Study for GW273225". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00483535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*